News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
foto_recurso_pastillas
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopardizes biotechnological innovation if improvements are not introduced
Healthcare · Access to innovation · Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies · Antibiotic resistance
Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in…
foto_recurso_parkinson
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative disease
Healthcare · Access to innovation · Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies
Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications…
Mercedes_Iriarte_Cela
#NewAseBioMember | “AseBio is the perfect platform for company collaboration, research synergies, agreements and potential investment”
Healthcare · Corporate
Meet Copal Scientific, our new member. We talked to its Mercedes Iriarte Cela, CEO.
Spinally
#NewAseBioMember | “AseBio represents a platform within the bioindustry ecosystem”
Healthcare · Corporate
Meet Spinally Medical, our new member. We talked to its Carles García-Vitoria, Co-fundador &…
células foto oryzon
ORYZON announces U.S. FDA clearance of CTEP-CRADA Phase I/II clinical trial sponsored by NCI for iadademstat plus immune checkpoint inhibitors in 1L extensive stage Small Cell Lung Cancer
Healthcare · Access to innovation
In combination with either atezolizumab or durvalumab. 
Partners - Oryzon Genomics
dolor_cronico_foo_recurso
Revolution in Pain Management straight from Spain: Introducing the Spinally Medical
Healthcare · Access to innovation
Spinally Medical introduces FuturaLead™, a subarachnoid device for spinal cord stimulation aimed at…
Susana de Antonio Head of Listing Spain de Euronext
#AseBioID24 | "AseBio Investor Day is a unique meeting point for companies and investors specialized in the biotechnological sector"
Healthcare · Access to innovation · Financing
With the aim of analyzing the Spanish biotechnological ecosystem and delving into the challenges…
AseBio - Euronext
One_Health_biotecnología_AseBio
Biotechnology lays the groundwork for the present and future of healthcare and drives the One Health approach
Healthcare · Drug discovery · Rare diseases · Personalized medicine · Advanced therapies · Antibiotic resistance · Climate change · Agrifood · Animal health
The health pipeline of AseBio includes 130 molecules for 150 indications being investigated by 40…
oryzon-noticia-socio-asebio-biotech
ORYZON realizará múltiples actividades corporativas en conferencias internacionales en abril
Corporate
The biopharmaceutical company has been invited to participate or attend different events of…
Partners - Oryzon Genomics